NEVRO CORP.
NVRO
NVRO was delisted on the 2nd of April, 2025.
195 hedge funds and large institutions have $2.62B invested in NEVRO CORP. in 2022 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 91 increasing their positions, 60 reducing their positions, and 32 closing their positions.
52% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 60
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 209 → 195 (-14)
11% less capital invested
Capital invested by funds: $2.96B → $2.62B (-$335M)
26% less call options, than puts
Call options by funds: $21.1M | Put options by funds: $28.4M
41% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 32
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$55.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$45.7M |
| 3 |
BlackRock
New York
|
+$41M |
| 4 |
PA
Perceptive Advisors
New York
|
+$32.7M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$23.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$198M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$128M |
| 3 |
HM
HealthCor Management
New York
|
-$33.2M |
| 4 |
SEI Investments
Oaks,
Pennsylvania
|
-$32.4M |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$22.8M |
NVRO Hedge Fund Activity: Q1 2022 in Review
195 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q1 2022, worth a combined $2.62B — down 11% from $2.96B a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of NVRO and 19 opened new positions — a net loss of 13 holders — while 60 trimmed existing stakes and 91 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $55.1M. The largest seller was Jackson Square Partners, exiting entirely with an estimated $198M sold.
- 195 institutional investors held NEVRO CORP. (NVRO) as of Q1 2022, down from 209 in Q4 2021.
- Funds reported $2.62B of NEVRO CORP. stock for Q1 2022, down 11% quarter-over-quarter.
- 19 funds opened new NEVRO CORP. positions in Q1 2022 and 32 closed out, a net change of -13 holders.
- The largest NEVRO CORP. buyer in Q1 2022 was T. Rowe Price Associates, an estimated $55.1M added.
- The largest NEVRO CORP. seller in Q1 2022 was Jackson Square Partners, an estimated $198M sold.
Based on aggregated 13F filings for Q1 2022.